BZPEERReading, trust and collaboration for research
Menu

Discover

GraphFollow connections around a paper, topic or saved view.

Workspaces

HomePick up where your research flow left off.InboxHandle requests, replies and notifications from one place.CollectionsCurate reading lists, evidence sets and shareable dossiers.ResearchSee your private provenance graph, trail and imports.CollaborationMove from discovery into focused discussion rooms.PublishDraft, preview and publish full-text research articles.

Network

ExpertsFind specialists worth following or asking for help.CommunitiesJoin research circles organized around shared work.PartnersSee external organizations active around the same topics.

Opportunities

ListingsBrowse roles, calls and collaborations with clearer fit signals.

Account

Log inReturn to your reading and collaboration workspace.Create accountStart saving work, following people and joining teams.
Log inCreate account

Researcher profile

Ahmad Chaddad

Ahmad Chaddad contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate
Computer VisionQuantitative MethodsArtificial Intelligenceeess.IVGenomicsMethodologyApplicationsGraphicsMachine Learning

Trust snapshot

Quick read

Trust 21 - EmergingVerification L1Unclaimed author
8works
0followers
9topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

8 published item(s)

preprint2026arXiv

GazeFormer-MoE: Context-Aware Gaze Estimation via CLIP and MoE Transformer

We present a semantics modulated, multi scale Transformer for 3D gaze estimation. Our model conditions CLIP global features with learnable prototype banks (illumination, head pose, background, direction), fuses these prototype-enriched global vectors with CLIP patch tokens and high-resolution CNN tokens in a unified attention space, and replaces several FFN blocks with routed/shared Mixture of Experts to increase conditional capacity. Evaluated on MPIIFaceGaze, EYEDIAP, Gaze360 and ETH-XGaze, our model achieves new state of the art angular errors of 2.49°, 3.22°, 10.16°, and 1.44°, demonstrating up to a 64% relative improvement over previously reported results. ablations attribute gains to prototype conditioning, cross scale fusion, MoE and hyperparameter. Our code is publicly available at https://github. com/AIPMLab/Gazeformer.

0 citations0 reviewsNo code linkedOpen access
preprint2026arXiv

GMGaze: MoE-Based Context-Aware Gaze Estimation with CLIP and Multiscale Transformer

Gaze estimation methods commonly use facial appearances to predict the direction of a person gaze. However, previous studies show three major challenges with convolutional neural network (CNN)-based, transformer-based, and contrastive language-image pre-training (CLIP)-based methods, including late fusion of image features, lack of factor-aware conditioning, and impractical capacity scaling. To address these challenges, we propose Globally-conditioned Multi-scale Gaze estimation (GMGaze), which leverages a multi-scale transformer architecture. Specifically, the model first introduces semantic prototype conditioning, which modulates the CLIP global image embedding using four learned prototype banks (i.e., illumination, background, head pose and appearance) to generate two complementary context-biased global tokens. These tokens, along with the CLIP patch and CNN tokens, are fused at the first layer. This early unified fusion prevents information loss common in late-stage merging. Finally, each token passes through sparse Mixture-of-Experts modules, providing conditional computational capacity without uniformly increasing dense parameters. For cross-domain adaptation, we incorporate an adversarial domain adaptation technique with a feature separation loss that encourages the two global tokens to remain de-correlated. Experiments using four public benchmarks (MPIIFaceGaze, EYEDIAP, Gaze360, and ETH-XGaze) show that GMGaze achieves mean angular errors of 2.49$^\circ$, 3.22$^\circ$, 10.16$^\circ$, and 1.44$^\circ$, respectively, outperforming previous baselines in all within-domain settings. In cross-domain evaluations, it provides state-of-the-art (SOTA) results on two standard transfer routes.

0 citations0 reviewsNo code linkedOpen access
preprint2022arXiv

Can autism be diagnosed with AI?

Radiomics with deep learning models have become popular in computer-aided diagnosis and have outperformed human experts on many clinical tasks. Specifically, radiomic models based on artificial intelligence (AI) are using medical data (i.e., images, molecular data, clinical variables, etc.) for predicting clinical tasks like Autism Spectrum Disorder (ASD). In this review, we summarized and discussed the radiomic techniques used for ASD analysis. Currently, the limited radiomic work of ASD is related to variation of morphological features of brain thickness that is different from texture analysis. These techniques are based on imaging shape features that can be used with predictive models for predicting ASD. This review explores the progress of ASD-based radiomics with a brief description of ASD and the current non-invasive technique used to classify between ASD and Healthy Control (HC) subjects. With AI, new radiomic models using the deep learning techniques will be also described. To consider the texture analysis with deep CNNs, more investigations are suggested to be integrated with additional validation steps on various MRI sites.

0 citations0 reviewsNo code linkedOpen access
preprint2022arXiv

Deep Radiomic Analysis for Predicting Coronavirus Disease 2019 in Computerized Tomography and X-ray Images

This paper proposes to encode the distribution of features learned from a convolutional neural network using a Gaussian Mixture Model. These parametric features, called GMM-CNN, are derived from chest computed tomography and X-ray scans of patients with Coronavirus Disease 2019. We use the proposed GMM-CNN features as input to a robust classifier based on random forests to differentiate between COVID-19 and other pneumonia cases. Our experiments assess the advantage of GMM-CNN features compared to standard CNN classification on test images. Using a random forest classifier (80\% samples for training; 20\% samples for testing), GMM-CNN features encoded with two mixture components provided a significantly better performance than standard CNN classification (p\,$<$\,0.05). Specifically, our method achieved an accuracy in the range of 96.00\,--\,96.70\% and an area under the ROC curve in the range of 99.29\,--\,99.45\%, with the best performance obtained by combining GMM-CNN features from both computed tomography and X-ray images. Our results suggest that the proposed GMM-CNN features could improve the prediction of COVID-19 in chest computed tomography and X-ray scans.

0 citations0 reviewsNo code linkedOpen access
preprint2022arXiv

Deep radiomic signature with immune cell markers predicts the survival of glioma patients

Imaging biomarkers offer a non-invasive way to predict the response of immunotherapy prior to treatment. In this work, we propose a novel type of deep radiomic features (DRFs) computed from a convolutional neural network (CNN), which capture tumor characteristics related to immune cell markers and overall survival. Our study uses four MRI sequences (T1-weighted, T1-weighted post-contrast, T2-weighted and FLAIR) with corresponding immune cell markers of 151 patients with brain tumor. The proposed method extracts a total of 180 DRFs by aggregating the activation maps of a pre-trained 3D-CNN within labeled tumor regions of MRI scans. These features offer a compact, yet powerful representation of regional texture encoding tissue heterogeneity. A comprehensive set of experiments is performed to assess the relationship between the proposed DRFs and immune cell markers, and measure their association with overall survival. Results show a high correlation between DRFs and various markers, as well as significant differences between patients grouped based on these markers. Moreover, combining DRFs, clinical features and immune cell markers as input to a random forest classifier helps discriminate between short and long survival outcomes, with AUC of 72\% and p=2.36$\times$10$^{-5}$. These results demonstrate the usefulness of proposed DRFs as non-invasive biomarker for predicting treatment response in patients with brain tumors.

0 citations0 reviewsNo code linkedOpen access
preprint2022arXiv

Future Artificial Intelligence tools and perspectives in medicine

Purpose of review: Artificial intelligence (AI) has become popular in medical applications, specifically as a clinical support tool for computer-aided diagnosis. These tools are typically employed on medical data (i.e., image, molecular data, clinical variables, etc.) and used the statistical and machine learning methods to measure the model performance. In this review, we summarized and discussed the most recent radiomic pipeline used for clinical analysis. Recent findings:Currently, limited management of cancers benefits from artificial intelligence, mostly related to a computer-aided diagnosis that avoids a biopsy analysis that presents additional risks and costs. Most AI tools are based on imaging features, known as radiomic analysis that can be refined into predictive models in non-invasively acquired imaging data. This review explores the progress of AI-based radiomic tools for clinical applications with a brief description of necessary technical steps. Explaining new radiomic approaches based on deep learning techniques will explain how the new radiomic models (deep radiomic analysis) can benefit from deep convolutional neural networks and be applied on limited data sets. Summary: To consider the radiomic algorithms, further investigations are recommended to involve deep learning in radiomic models with additional validation steps on various cancer types.

0 citations0 reviewsNo code linkedOpen access
preprint2022arXiv

Gaze Estimation Approach Using Deep Differential Residual Network

Gaze estimation, which is a method to determine where a person is looking at given the person&#39;s full face, is a valuable clue for understanding human intention. Similarly to other domains of computer vision, deep learning (DL) methods have gained recognition in the gaze estimation domain. However, there are still gaze calibration problems in the gaze estimation domain, thus preventing existing methods from further improving the performances. An effective solution is to directly predict the difference information of two human eyes, such as the differential network (Diff-Nn). However, this solution results in a loss of accuracy when using only one inference image. We propose a differential residual model (DRNet) combined with a new loss function to make use of the difference information of two eye images. We treat the difference information as auxiliary information. We assess the proposed model (DRNet) mainly using two public datasets (1) MpiiGaze and (2) Eyediap. Considering only the eye features, DRNet outperforms the state-of-the-art gaze estimation methods with $angular-error$ of 4.57 and 6.14 using MpiiGaze and Eyediap datasets, respectively. Furthermore, the experimental results also demonstrate that DRNet is extremely robust to noise images.

0 citations0 reviewsNo code linkedOpen access
preprint2022arXiv

Modeling of Textures to Predict Immune Cell Status and Survival of Brain Tumour Patients

Radiomics has shown a capability for different types of cancers such as glioma to predict the clinical outcome. It can have a non-invasive means of evaluating the immunotherapy response prior to treatment. However, the use of deep convolutional neural networks (CNNs)-based radiomics requires large training image sets. To avoid this problem, we investigate a new imaging features that model distribution with a Gaussian mixture model (GMM) of learned 3D CNN features. Using these deep radiomic features (DRFs), we aim to predict the immune marker status (low versus high) and overall survival for glioma patients. We extract the DRFs by aggregating the activation maps of a pre-trained 3D-CNN within labeled tumor regions of MRI scans that corresponded immune markers of 151 patients. Our experiments are performed to assess the relationship between the proposed DRFs, three immune cell markers (Macrophage M1, Neutrophils and T Cells Follicular Helper), and measure their association with overall survival. Using the random forest (RF) model, DRFs was able to predict the immune marker status with area under the ROC curve (AUC) of 78.67, 83.93 and 75.67\% for Macrophage M1, Neutrophils and T Cells Follicular Helper, respectively. Combined the immune markers with DRFs and clinical variables, Kaplan-Meier estimator and Log-rank test achieved the most significant difference between predicted groups of patients (short-term versus long-term survival) with p\,=\,4.31$\times$10$^{-7}$ compared to p\,=\,0.03 for Immune cell markers, p\,=\,0.07 for clinical variables , and p\,=\,1.45$\times$10$^{-5}$ for DRFs. Our findings indicate that the proposed features (DRFs) used in RF models may significantly consider prognosticating patients with brain tumour prior to surgery through regularly acquired imaging data.

0 citations0 reviewsNo code linkedOpen access